{"title":"Association of Antenatal Corticosteroid Administration-to-Birth Intervals With Mortality and Morbidity Among Extremely Preterm Infants: Multicenter Data from Shenzhen, China.","authors":"Fengji Lin, Jing Feng, Hai-Ping Cheng, Kang-Hua Zhou, Dan-Dan Rao, Yuan-Yuan Li, Gui-Lian Du, Hui-Ying Tu, Li-Fen Rao, Xin Guo","doi":"10.1159/neo/adsag045","DOIUrl":"https://doi.org/10.1159/neo/adsag045","url":null,"abstract":"<p><strong>Introduction: </strong>The optimal interval between antenatal corticosteroid (ACS) administration and birth remains uncertain, and Chinese multicentre data are scarce.</p><p><strong>Methods: </strong>In this multicentre retrospective cohort, 1,328 infants born before 32 weeks were classified by ACS-to-birth interval: none, <24 hours, 24 hours-7 days or >7 days. The primary outcome was survival without major morbidity (SWMM).</p><p><strong>Results: </strong>Only the 24 hours-7 days interval was associated with lower pre-discharge death, treated patent ductus arteriosus (PDA) and severe brain injury, and higher SWMM. Intervals <24 hours reduced death and severe retinopathy of prematurity (sROP) only; intervals >7 days improved SWMM, severe brain injury and sROP without survival benefit. Severe intraventricular hemorrhage risk rose nonlinearly at short intervals. A single complete course conferred the broadest protection, with graded reductions in treated PDA.</p><p><strong>Conclusion: </strong>ACS benefits are interval- and outcome-specific; 24 hours-7 days provided the broadest protection, supporting individualized regimens.</p>","PeriodicalId":94152,"journal":{"name":"Neonatology","volume":" ","pages":""},"PeriodicalIF":3.0,"publicationDate":"2026-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149418841","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
NeonatologyPub Date : 2026-11-14DOI: 10.1159/neo/adsag042
Irene Gutierrez-Rosa, Carmen Rodríguez-Barrios, Manuel Lubián-Gutiérrez, Isabel Benavente-Fernández, Simón Pedro Lubián-López
{"title":"Cumulative Hyperglycemic Exposure and Intraventricular Hemorrhage in Very Preterm Infants.","authors":"Irene Gutierrez-Rosa, Carmen Rodríguez-Barrios, Manuel Lubián-Gutiérrez, Isabel Benavente-Fernández, Simón Pedro Lubián-López","doi":"10.1159/neo/adsag042","DOIUrl":"https://doi.org/10.1159/neo/adsag042","url":null,"abstract":"<p><strong>Introduction: </strong>Current definitions of neonatal hyperglycemia rely on isolated glucose measurements and static thresholds, despite the dynamic evolution of glucose homeostasis in very preterm infants. Whether cumulative hyperglycemic exposure during the early postnatal period is associated with intraventricular hemorrhage (IVH) remains uncertain.</p><p><strong>Methods: </strong>We conducted a prospective cohort study of very preterm infants (≤32 weeks' gestation and/or ≤1500 g birth weight). Cumulative hyperglycemic exposure during the first 5 postnatal days was quantified using continuous glucose monitoring and evaluated using both conventional glucose thresholds and developmentally derived gestational age- and postnatal day-specific reference thresholds. The primary outcome was IVH, defined as grade II-III IVH or periventricular hemorrhagic infarction (PVHI).</p><p><strong>Results: </strong>Among 176 infants, 25 (14.2%) developed IVH. Infants with IVH experienced greater cumulative hyperglycemic exposure during the first 5 postnatal days. Cumulative exposure above the gestational age- and postnatal day-specific upper reference interval remained independently associated with IVH after adjustment for relevant clinical factors. Predicted risk increased progressively with increasing hyperglycemic burden, supporting an exposure-response relationship.</p><p><strong>Conclusions: </strong>Cumulative hyperglycemic exposure during the early postnatal period was independently associated with IVH in very preterm infants. Developmentally derived glucose thresholds incorporating gestational age and postnatal age may improve characterization of dysglycemia-related neurological risk.</p>","PeriodicalId":94152,"journal":{"name":"Neonatology","volume":" ","pages":""},"PeriodicalIF":3.0,"publicationDate":"2026-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149414445","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
NeonatologyPub Date : 2026-11-14DOI: 10.1159/neo/adsag044
Kamal Ali, Abdulaziz Homedi, Saleh Algarni, Saad Alshareedah, Mohammed Sufyani, Omar Almutairi, Saif Alsaif, Ibrahim Ali, Theodore Dassios, Anne Greenough
{"title":"Physiological and clinical comparison of two high-frequency oscillatory ventilation with volume guarantee strategies in preterm infants with respiratory distress syndrome.","authors":"Kamal Ali, Abdulaziz Homedi, Saleh Algarni, Saad Alshareedah, Mohammed Sufyani, Omar Almutairi, Saif Alsaif, Ibrahim Ali, Theodore Dassios, Anne Greenough","doi":"10.1159/neo/adsag044","DOIUrl":"https://doi.org/10.1159/neo/adsag044","url":null,"abstract":"<p><strong>Objective: </strong>To compare the physiological performance and clinical outcomes of two high-frequency oscillatory ventilation with volume guarantee (HFOV-VG) strategies in preterm infants born at less than 30 weeks of gestation.</p><p><strong>Methods: </strong>In this retrospective cohort study, 88 preterm infants born at less than 30 weeks of gestation received either a low-VThf/high-frequency strategy (oscillatory frequency 15-17 Hz; measured VThf/kg 1.5-1.9 mL/kg; n=61) or a high-VThf/standard-frequency strategy (oscillatory frequency 10-12 Hz; measured VThf/kg 2.0-3.0 mL/kg; n=27). Minute-level ventilator and paired arterial blood gas data were analysed. Clinical outcomes included moderate-to-severe bronchopulmonary dysplasia (BPD), mortality, and duration of invasive mechanical ventilation.</p><p><strong>Results: </strong>A total of 267,786 ventilator observations and 825 paired blood gas observations were analysed. PaCO₂ was comparable between strategies (50 [44-56] vs 49 [43-57] mmHg; p=0.67). The low-VThf/high-frequency strategy was associated with lower FiO₂ requirements, reduced oscillatory pressure variability, and shorter invasive mechanical ventilation (10 [6-21] vs 24 [12-39] days; p=0.0005). After adjustment for gestational age, antenatal corticosteroid exposure, and baseline oxygenation index, the high-VThf/standard-frequency strategy remained independently associated with longer invasive mechanical ventilation (duration ratio 1.65, 95% CI 1.13-2.41; p=0.009), but not moderate-to-severe BPD.</p><p><strong>Conclusions: </strong>In preterm infants born at less than 30 weeks of gestation, a low-VThf/high-frequency HFOV-VG strategy maintained comparable arterial PaCO₂ control while reducing respiratory support requirements, supporting its use as a physiologically favourable ventilation strategy.</p>","PeriodicalId":94152,"journal":{"name":"Neonatology","volume":" ","pages":""},"PeriodicalIF":3.0,"publicationDate":"2026-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149414446","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
NeonatologyPub Date : 2026-11-13DOI: 10.1159/neo/adsag043
Juliann M Di Fiore, Anna Maria Hibbs, Nori Mercuri Minich, Namasivayam Ambalavanan, Yuxi Zhu, Richard J Martin
{"title":"Relationship between Darbepoetin and Intermittent Hypoxemia in Preterm Infants.","authors":"Juliann M Di Fiore, Anna Maria Hibbs, Nori Mercuri Minich, Namasivayam Ambalavanan, Yuxi Zhu, Richard J Martin","doi":"10.1159/neo/adsag043","DOIUrl":"https://doi.org/10.1159/neo/adsag043","url":null,"abstract":"<p><strong>Objective: </strong>In the Darbepoetin to Improve Red Cell Mass and Neuroprotection in Preterm Infants Trial (Darbe; NCT03169881), infants <29wks gestation receiving darbepoetin were less likely to develop bronchopulmonary dysplasia (BPD) and had higher hematocrit and red blood cell counts (RBC) suggesting that darbepoetin may augment tissue oxygen delivery and thereby improve respiratory outcomes. Intermittent hypoxemia (IH) is associated with an increased risk of BPD, and it is possible that darbepoetin reduces BPD by attenuating IH.</p><p><strong>Study design: </strong>A subcohort of 94 infants enrolled in Darbe were retrospectively analyzed. Number, duration, nadir and total time with IH <90% and <80% were identified through 42 days of age on continuous oxygen saturation recordings. Hematocrit and RBC counts were documented at days 14 and 42.</p><p><strong>Results: </strong>Darbepoetin infants had a higher hematocrit at day 42 and there were fewer IH events <80% with a higher hematocrit (β=-1.51, 95% CI (-2.67, -0.36), p=0.03). However, the effect of darbepoetin supplementation on patterns of IH was limited to a significantly higher nadir (less severe) for IH <80% (β=-0.02, 95% CI (-0.04, 0), p=0.04).</p><p><strong>Conclusions: </strong>Darbepoetin increases hematocrit but only modestly improves oxygen stability in preterm infants.</p>","PeriodicalId":94152,"journal":{"name":"Neonatology","volume":" ","pages":""},"PeriodicalIF":3.0,"publicationDate":"2026-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149414447","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
NeonatologyPub Date : 2026-11-10DOI: 10.1159/neo/adsag032
Manal Massalha, Bryon DeFrance, Kinga Malinowski, Nathoo Sahra, Jon F Barrett, Eran Ashwal
{"title":"Neonatal Morbidity Across the Fetal Growth Spectrum in Gestational Diabetes Mellitus.","authors":"Manal Massalha, Bryon DeFrance, Kinga Malinowski, Nathoo Sahra, Jon F Barrett, Eran Ashwal","doi":"10.1159/neo/adsag032","DOIUrl":"https://doi.org/10.1159/neo/adsag032","url":null,"abstract":"<p><strong>Objective: </strong>Gestational diabetes mellitus (GDM) is linked to fetal overgrowth and, less commonly, fetal growth restriction (FGR). Few studies have examined neonatal outcomes across the full birthweight spectrum while incorporating antenatal Doppler findings. We evaluated the association between birthweight/Doppler-defined growth category and neonatal outcomes in singleton GDM pregnancies.</p><p><strong>Method: </strong>In a retrospective cohort (2011-2024) of singleton GDM pregnancies delivering at ≥32 weeks, growth categories were assigned after delivery using Hadlock birthweight percentiles and antenatal Doppler findings from the last ultrasound within 14 days of delivery. FGR was defined as birthweight <3rd percentile or 3rd-<10th percentile with an abnormal Doppler criterion; SGA was 3rd-<10th percentile without an abnormal available Doppler criterion. The primary outcome was a composite of arterial cord pH <7.1, 5-minute Apgar <7, neonatal hospital stay >2 days, or phototherapy. Multivariable logistic regression adjusted for maternal and obstetric factors.</p><p><strong>Results: </strong>Among 2,099 pregnancies, 7.7% were FGR, 7.5% SGA, 71.8% AGA, and 13.0% LGA. Composite morbidity occurred in 50% of FGR, 40.7% LGA, 29.3% SGA, and 29.1% AGA (p<0.001). FGR (aOR 1.97, 95% CI 1.32-2.92) and LGA (aOR 1.36, 95% CI 1.00-1.85) predicted increased morbidity; SGA did not. The FGR association persisted at term (aOR 1.72, 95% CI 1.10-2.68).</p><p><strong>Conclusion: </strong>In GDM, FGR and LGA were associated with greater neonatal morbidity. SGA without an abnormal available Doppler criterion was not associated with increased morbidity compared with AGA. These findings support prospective evaluation of Doppler-based risk stratification among small fetuses.</p>","PeriodicalId":94152,"journal":{"name":"Neonatology","volume":" ","pages":""},"PeriodicalIF":3.0,"publicationDate":"2026-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149389159","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
NeonatologyPub Date : 2026-11-07DOI: 10.1159/neo/adsag040
Howard Stein, Kimberly S Firestone, David N Matlock, Maher S Shahroor, Ricardo E Rodriguez, Matthew J Kielt, Ebewa Erebor, Sherry Courtney, Haresh Kirpalani, Kevin Dysart, Karen Warren, Mitchell Goldstein, Rakesh Rao, Jesse Y Hsu, Sarah J Ratcliffe, Elizabeth E Foglia
{"title":"Designing and Implementing a Run-In Phase to Ensure Site Performance for a Multicenter Neonatal Ventilator Trial.","authors":"Howard Stein, Kimberly S Firestone, David N Matlock, Maher S Shahroor, Ricardo E Rodriguez, Matthew J Kielt, Ebewa Erebor, Sherry Courtney, Haresh Kirpalani, Kevin Dysart, Karen Warren, Mitchell Goldstein, Rakesh Rao, Jesse Y Hsu, Sarah J Ratcliffe, Elizabeth E Foglia","doi":"10.1159/neo/adsag040","DOIUrl":"https://doi.org/10.1159/neo/adsag040","url":null,"abstract":"<p><strong>Introduction: </strong>Multicenter clinical trials evaluating performance-dependent interventions are particularly vulnerable to variability in technical proficiency and protocol adherence across participating sites. Despite the potential impact of this variability on trial validity, there is little published guidance describing how to prepare and qualify sites before subject randomization. We describe the rationale, design, implementation, and lessons learned from a structured Run-In Phase developed for the multicenter Diaphragmatic Initiated Ventilatory Assist (DIVA) trial and to provide practical recommendations for future performance-based clinical trials.</p><p><strong>Methods: </strong>The DIVA trial incorporated a prospective site-level Run-In Phase before randomization to evaluate each site's ability to consistently deliver non-invasive neurally adjusted ventilatory assist (NIV-NAVA). The Run-In Phase included formation of an expert technical committee, standardized educational materials, boot camp and on-site multidisciplinary training, continuous technical support, and objective assessment of technical competency using predefined performance metrics. Sites were required to demonstrate successful management of a minimum number of patients and adherence to protocol-defined standards before progressing to the randomized phase. Perspectives from principal investigators, site investigators, research coordinators, and the data coordinating center were incorporated to evaluate the operational impact of the Run-In Phase.</p><p><strong>Conclusions: </strong>A structured Run-In Phase provides a systematic framework for assessing and supporting intervention fidelity, reducing performance-related variability, and preparing sites for multicenter trials involving technically complex, operator-dependent interventions. Although resource intensive, a structured Run-In Phase provides a reproducible framework for preparing sites to deliver technically complex, performance-dependent interventions and for identifying and addressing implementation challenges before initiation of the randomized phase. We recommend broader adoption and standardized reporting of Run-In Phases in multicenter performance-based clinical trials.</p>","PeriodicalId":94152,"journal":{"name":"Neonatology","volume":" ","pages":""},"PeriodicalIF":3.0,"publicationDate":"2026-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149372681","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
NeonatologyPub Date : 2026-11-06DOI: 10.1159/neo/adsag039
Christian Poets, Cornelia Wiechers, Teresa Thomas, Günther Heller, Harald Abele, Axel R Franz
{"title":"National registry data on the neonatal outcome of infants born at 22-25 weeks in Germany.","authors":"Christian Poets, Cornelia Wiechers, Teresa Thomas, Günther Heller, Harald Abele, Axel R Franz","doi":"10.1159/neo/adsag039","DOIUrl":"https://doi.org/10.1159/neo/adsag039","url":null,"abstract":"<p><strong>Introduction: </strong>There are no population-based data on neonatal outcomes of infants born in Germany at 22-25 weeks' gestation. We set out to obtain national data on neonatal outcomes of infants born at 22-25 weeks gestation.</p><p><strong>Methods: </strong>We analyzed mandatory quality control data submitted by all neonatal intensive care units on all infants born alive in Germany at 220/7 to 256/7 weeks' gestation and generating a neonatal case who died or were discharged between 1/1/2014 and 31/12/2023, focusing on survival to discharge/transfer and survival without severe complications of prematurity.</p><p><strong>Results: </strong>The number of live-births totaled 1889 at 22, 3405 at 23, 5193 at 24 weeks, and 5572 at 25 weeks. The proportion of infants offered intensive care at birth increased from 39.9% at 22 to 98.9% at 25 weeks. Across the 10-year study period, this proportion increased from 37.6% (2014-2018) to 42.2% (2019-2023; p=0.04) for infants born at 22 weeks, but did not change at higher gestations. Survival in those offered intensive care at birth ranged from 41.4% at 22 weeks to 84.1% at 25 weeks. Survival without severe complications of prematurity in those offered intensive care increased from 8.0% to 43.0% between 22 and 25 weeks.</p><p><strong>Conclusions: </strong>In Germany, ∼40% of infants born alive at 22 weeks were offered intensive care at birth, of whom ∼40% survived. In these survivors, about 20% were discharged without severe neonatal complications. These population-based data may help to counsel parents with imminent birth at 22-23 weeks. The low number of live births at 22 and 23 weeks may reflect withholding of proactive prenatal management. Future studies should also ascertain deaths before labor and during delivery.</p>","PeriodicalId":94152,"journal":{"name":"Neonatology","volume":" ","pages":""},"PeriodicalIF":3.0,"publicationDate":"2026-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149345261","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
NeonatologyPub Date : 2026-10-24DOI: 10.1159/neo/adsag024
Aimilia Eirini Papathanasiou, Daniela Bullard Elias, Laura Bellew, Monir Hossain, Aisaku Nakamura, Nehal Parikh, Jason Woods, Erik B Hysinger
{"title":"Trajectories of Pulmonary Function and Dysanapsis after Premature Birth.","authors":"Aimilia Eirini Papathanasiou, Daniela Bullard Elias, Laura Bellew, Monir Hossain, Aisaku Nakamura, Nehal Parikh, Jason Woods, Erik B Hysinger","doi":"10.1159/neo/adsag024","DOIUrl":"https://doi.org/10.1159/neo/adsag024","url":null,"abstract":"<p><p>Background/Objectives Preterm survivors, with or without bronchopulmonary dysplasia (BPD) have decreased and progressive lung function decline. As neonatal care has improved survival, limited studies have compared lung function trajectories across birth epochs. Methods Retrospective study of subjects born <33 weeks who completed ≥1 pulmonary function test (PFT). BPD was classified per 2019 NICHD criteria. We analyzed spirometry values and Dysanapsis Ratio (DR). Birth epochs included Epoch A(<2000), B (2000-2009), and C(2010-2019). Results We analyzed 2,216 PFTs from 707 subjects; 319 (45.1%) had BPD. Pulmonary function decreased with increasing BPD severity. FEV1 decreased monotonically, from 92.0%(80.1-102.0) in preterm without BPD to 73.1%(57.7-84.9) in Grade 3, with consistent decreases in FVC (99.0%(87.0-110.0) to 85.2%(71.5-93.4). FEV₁/FVC remained largely constant, with a small decrease in Grade 3. Due to divergence in FEV1 and FVC trend with increasing age, FEV1/FVC yearly decline slope tripled in more recent epochs in subjects with BPD (Epoch A:-0.4%/yr(-0.8 to 0.05), B:-0.8%/yr(-1.1 to -0.5),, C:-1.4%/yr(-1.8 to -0.9). Similarly, DR decreased with age, with steeper decline in more recent epochs (Epoch A:-0.01/yr(-0.02 to -0.0004), B:-0.02/yr(-0.03 to -0.01), C:-0.04/yr(-0.05 to -0.03). Similar declines were noted for FEV1/FVC and DR in children without BPD. Conclusion In preterm survivors, lung function declined with increasing BPD severity and age. Lung function was reduced and declined in preterm children without BPD. Recent birth epochs exhibited faster decline in FEV1/FVC and worsening DR, indicating evolving airway-parenchymal growth mismatch despite advances in neonatal care, highlighting the need for longitudinal follow-up and targeted interventions to improve long-term outcomes.</p>","PeriodicalId":94152,"journal":{"name":"Neonatology","volume":" ","pages":"1"},"PeriodicalIF":3.0,"publicationDate":"2026-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149279181","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
NeonatologyPub Date : 2026-10-23DOI: 10.1159/neo/adsag035
Céline Weber, Thomas Menter, Raphael N Vuille-Dit-Bille, Philipp Meyer, Stefan Gerhard Holland-Cunz, Maya Caroline Andre
{"title":"Fulminant necrotizing enterocolitis associated with severe RSV infection in a preterm infant following Nirsevimab prophylaxis: a case report.","authors":"Céline Weber, Thomas Menter, Raphael N Vuille-Dit-Bille, Philipp Meyer, Stefan Gerhard Holland-Cunz, Maya Caroline Andre","doi":"10.1159/neo/adsag035","DOIUrl":"https://doi.org/10.1159/neo/adsag035","url":null,"abstract":"<p><p>Respiratory syncytial virus (RSV) prophylaxis with the monoclonal antibody Nirsevimab has shown high efficacy in preventing severe lower respiratory tract infections in infants. However, the sequences of immunopathological phenomena leading to breakthrough infections and the role of RSV in causing extrapulmonary disease remain poorly understood. We report on a former preterm infant who developed an unusually severe form of necrotizing enterocolitis (NEC) requiring multiple emergency laparotomies and prolonged intensive care treatment in the context of severe RSV-bronchiolitis 22 days after passive immunization with Nirsevimab. RSV RNA was retrospectively detected using a validated RSV PCR assay in resected intestinal tissue obtained during the acute disease phase but was not detected in tissue collected during later surgical reconstruction. Our case highlights the need for clinicians to maintain a high index of suspicion for intestinal complications in infants with severe RSV infection. Although these findings raise the possibility of intestinal RSV involvement, a causal relationship between Nirsevimab prophylaxis, antibody-dependent enhancement (ADE), and NEC cannot be established from this single case. Confirmation in additional clinical and translational studies is required. Further clinical and translational studies are required to clarify the potential role of RSV in intestinal disease and the mechanisms underlying severe breakthrough infections.</p>","PeriodicalId":94152,"journal":{"name":"Neonatology","volume":" ","pages":"1"},"PeriodicalIF":3.0,"publicationDate":"2026-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149248252","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
NeonatologyPub Date : 2026-10-23DOI: 10.1159/neo/adsag037
Ida Lagerström, Jonas Soderling, Neda Razaz, Maria Altman, Stefan Johansson, Jenny Bolk
{"title":"Mortality among infants with Apgar score 0 at 10 minutes.","authors":"Ida Lagerström, Jonas Soderling, Neda Razaz, Maria Altman, Stefan Johansson, Jenny Bolk","doi":"10.1159/neo/adsag037","DOIUrl":"https://doi.org/10.1159/neo/adsag037","url":null,"abstract":"<p><strong>Introduction: </strong>An Apgar score of 0 at 10 minutes is considered an indicator of poor prognosis and has historically influenced decisions regarding neonatal resuscitation. However, mortality estimates are largely based on small heterogeneous studies. We examined infant mortality among infants with Apgar score 0 at 10 minutes and compared mortality with that among infants with Apgar scores of 1, 2, or 3.</p><p><strong>Methods: </strong>This nationwide population-based cohort study included 2,638,291 singleton live births in Sweden from 1999 to 2024. Analyses included 1,608 infants born at ≥36 weeks' gestation with an Apgar score of 0 to 3 at 10 minutes after birth. The primary outcome was all-cause infant mortality. Adjusted risk ratios (aRRs) with 95% confidence intervals (CIs) were estimated using modified Poisson regression.</p><p><strong>Results: </strong>Of 1,608 infants, 277 had an Apgar score of 0, 327 a score of 1, 398 a score of 2, and 606 a score of 3 at 10 minutes. Among infants with Apgar score 0, 143 infants (51.6%) died within the first year. The aRRs (95% CIs) for infant mortality were 1.16 (0.98-1.37) compared with Apgar score 1, 2.48 (1.99-3.09) compared with Apgar score 2, and 2.85 (2.32-3.51) compared with Apgar score 3.</p><p><strong>Conclusion: </strong>Infant mortality did not differ statistically significantly between infants with Apgar scores of 0 and 1 at 10 minutes, and was higher in both groups than among infants with Apgar scores of 2 or 3. These findings are consistent with resuscitation guidelines emphasizing individualized decision-making.</p>","PeriodicalId":94152,"journal":{"name":"Neonatology","volume":" ","pages":"1"},"PeriodicalIF":3.0,"publicationDate":"2026-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149248305","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}